Interleukin-1 receptor-associated kinase 3 (IRAK3) has been proven to be overexpressed in arthritis and to perform antagonistically in Toll-like receptor (TLR)-mediated cellular signaling [83,84]. Here, IRAK3 is linked to arthritic joint disease.